Novartis AG Inventory Writedown2011
Novartis AG (NVSEF) reported Inventory Writedown2011 of $532.00 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-02-04.
Financial Statements › Notes › Inventory
ifrs-full:InventoryWritedown2011 · last filed 2026-02-04
| Period end | Inventory Writedown2011 12 month | Inventory Writedown2011 12 month as first filed |
|---|---|---|
| 2025-12-31 | $532.00M 20-F · filed 2026-02-04 | |
| 2024-12-31 | $526.00M 20-F · filed 2026-02-04 | |
| 2023-12-31 | $467.00M 20-F · filed 2026-02-04 | |
| 2022-12-31 | $373.00M 20-F · filed 2025-01-31 | $633.00M 20-F · filed 2023-02-01 |
| 2021-12-31 | $283.00M 20-F · filed 2024-01-31 | $573.00M 20-F · filed 2022-02-02 |
| 2020-12-31 | $702.00M 20-F/A · filed 2023-05-15 | |
| 2019-12-31 | $752.00M 20-F · filed 2022-02-02 | -$752.00M 20-F · filed 2020-01-29 |
| 2018-12-31 | $603.00M 20-F · filed 2021-01-26 | $751.00M 20-F · filed 2019-01-30 |
| 2017-12-31 | -$416.00M 20-F · filed 2020-01-29 | $470.00M 6-K · filed 2018-01-24 |
| 2016-12-31 | $283.00M 20-F · filed 2019-01-30 | |
| 2015-12-31 | $356.00M 6-K · filed 2018-01-24 |